Progress in Pharmacotherapy of Borderline Disorders: A Double-blind Study of Amitriptyline, Haloperidol, and Placebo

Archives of General Psychiatry

Volumn 43, Issue 7, 1986, Pages 691-697

  Soloff, Paul H ^a   George, Anselm ^a   Nathan, R Swami ^a   Schulz, Patricia M ^a   Ulrich, Richard F ^a   Perel, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BIPERIDEN; CHLORPROMAZINE; HALOPERIDOL; IMIPRAMINE; PHENELZINE; PLACEBO; PROCYCLIDINE; TIOTIXENE; TRANYLCYPROMINE; TRIFLUOPERAZINE;

BORDERLINE STATE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; THERAPY;

ADOLESCENT; ADULT; AMITRIPTYLINE; BORDERLINE PERSONALITY DISORDER; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PERSONALITY DISORDERS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 0022636013     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1986.01800070081010     Document Type: Article

References (48)

1. Andrulonis PA, Glueck BL, Stroebel CF, Vogel NG, Shapiro AL, Aldridge DM: Organic brain dysfunction and the borderline syndrome. Psychiatr Clin North Am 1981;4:61-66.
2. Kernberg O: Borderline Conditions and Pathological Narcissism. New York, Jason Aronson Inc, 1975, pp 131-132.
3. Chessick RD: The borderline patient, in Arieti S, Brady E (eds): American Handbook of Psychiatry III. New York, Basic Books Inc, 1974, pp 808-819.
4. Dyrud JE: The treatment of the borderline syndrome, in Offer E, Freedman DX (eds): Modern Psychiatry and Clinical Research. New York, Basic Books Inc, 1972, pp 159-173.
5. Waldinger RJ, Gunderson JG: Completed psychotherapies with borderline patients. Am J Psychother 1984;38:190-202.
6. Soloff PH: Pharmacotherapy of borderline disorders. Compr Psychiatry 1981;22:535-543.
7. Cole JO, Salomon M, Gunderson J, Sunderland P III, Simmonds P: Drug therapy in borderline patients. Compr Psychiatry 1984;25:249-254.
8. Cole JO, Sunderland P: The drug treatment of borderline patients, in Grinspoon L (ed): Psychiatry 1982 Annual Review. Washington, DC, American Psychiatric Press Inc, pp 415-437.
9. Brinkley JR, Beitman BD, Friedel RO: Low dose neuroleptic regimes in the treatment of borderline patients. Arch Gen Psychiatry 1979;36:319-326.
10. Gunderson JG, Singer MT: Defining borderline patients: An overview. Am J Psychiatry 1975;132:1-10.
11. Leone NF: Response of borderline patients to loxapine and chlorpromazine. J Clin Psychiatry 1982;43:148-150.
12. Gunderson JG, Kolb JE: Discriminating features of borderline patients. Am J Psychiatry 1978;135:792-796.
13. Serban G, Siegel S: Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 1984;141:1455-1458.
14. Faltus FJ: The positive effect of alprazolam in the treatment of three patients with borderline personality disorder. Am J Psychiatry 1984;141:802-803.
15. Gardner DL, Cowdry RW: Alprazolam-induced dyscontrol in borderline personality disorder. Am J Psychiatry 1985;142:98-100.
16. Fink M, Pollack M, Klein DF, Blumberg AG, Belmont I, Karp E, Kramer JC, Willner A: Comparative studies of chlorpromazine and imipramine: I. Drug discriminating patterns, in Bradley PB, Flügel F, Hoch PH (eds): Neuropsychopharmacology. New York, Elsevier Publishing Co, 1964, vol 3, pp 370-372.
17. Hedberg DL, Hauch JH, Glueck BL: Tranylcypromine-trifluoperazine combination in the treatment of schizophrenia. Am J Psychiatry 1971;127:1141-1146.
18. Liebowitz MR, Klein DF: Interrelationship of hysteroid dysphoria and borderline personality disorder. Psychiatr Clin North Am 1981;4:67-89.
19. Rifkin A, Quitkin F, Carrillo C, Blumberg AG, Klein DF: Lithium carbonate in emotionally unstable character disorders. Arch Gen Psychiatry 1972;27:519-523.
20. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF: Psychopharmacologic validation of atypical depression. J Clin Psychiatry 1984;45:22-25.
21. Gunderson JG, Kolb JE, Austin V: The diagnostic interview for borderline patients. Am J Psychiatry 1981;138:896-903.
22. Kolb JE, Gunderson JG: Diagnosing borderline patients with a semistructured interview. Arch Gen Psychiatry 1980;37:37-41.
23. American Psychiatric Association Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
24. Soloff PH, Millward JW: Psychiatric disorders in the families of borderline patients. Arch Gen Psychiatry 1983;40:37-48.
25. Gunderson JG, Carpenter WT, Strauss JS: Borderline and schizophrenic patients: A comparative study. Am J Psychiatry 1975;132:1259-1264.
26. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria for a Selected Group of Functional Disorders, ed 3. National Institute of Mental Health Clinical Research Branch Collaborative Program on the Psychology of Depression, 1977.
27. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia-Lifetime Version. National Institute of Mental Health, June 1977.
28. Kroll J, Sines L, Martin K, Lari S, Pyle R, Zander J: Borderline personality disorder: Construct validity of the concept. Arch Gen Psychiatry 1981;38:1021-1026.
29. Pope HG, Jonas JM, Hudson JI, Cohen BM, Gunderson JG: The validity of DSM-III borderline personality disorder. Arch Gen Psychiatry 1983;40:23-30.
30. Gunderson JG, Elliott GR: The interface between borderline personality disorder and affective disorders. Am J Psychiatry 1985;142:227-288.
31. Spitzer RL, Gibbon M, Endicott J: The global assessment scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-771.
32. Hamilton M: A psychiatric rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
33. Lorr M, Klett CJ: Inpatient Multidimensional Psychiatric Scale: Manual. Palo Alto, Calif, Consulting Psychologists Press, 1966.
34. Ziegler VE, Co BT, Taylor JR, Clayton PJ, Biggs JT: Amitriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 1976;19:795-801.
35. Braithwaite RA, Goulding R, Theano G, Bailey J, Coppen A: Plasma concentration of amitriptyline and clinical response. Lancet 1972;1:1297-1300.
36. Kupfer DJ, Hanin I, Spiker D, Neil J, Coble P, Grau T, Nevar C: Amitriptyline plasma levels and clinical response in primary depression: II. Commun Psychopharmacol 1978;2:441-450.
37. Forsman A, Ohman R: On the objective evaluation of haloperidol effects in man: A pilot study. Curr Ther Res 1978;24:179-192.
38. Magliozzi JR, Hollister LE, Arnold KV, Earle GM: Relationship of serum haloperidol levels to clinical response in schizophrenic patients. AmJ Psychiatry 1981;138:365-367.
39. Smith RC, Crayton J, Dekirmenjian H: Blood levels of neuroleptic drugs in non-responding chronic schizophrenic patients. Arch Gen Psychiatry 1979;36:579-584.
40. Derogatis LR, Lipman RS, Covi L: SCL-90: An outpatient psychiatric rating scale—preliminary report. Psychopharmacology Bull 1973;9:13-28.
41. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
42. Spitzer RL, Endicott J, Gibbon M: Crossing the border into borderline personality and borderline schizophrenia: The development of criteria. Arch Gen Psychiatry 1979;36:17-24.
43. Khouri PJ, Haier RJ, Rieder RO, Rosenthal D: A symptom schedule for the diagnosis of borderline schizophrenia: A first report. Br J Psychiatry 1980;137:140-147.
44. Meehl PE: Manual for Use With Checklist of Schizotypic Signs. Minneapolis, University of Minnesota, 1964.
45. Stiller RL, Marynowski SW, Perel JM: Gas chromatography of tricyclic antidepressants at picogram levels with glass capillary column and nitrogen sensitive detection. Fed Proc 1979;38:545.
46. Shostak M, Perel J: Radioimmunoassay for haloperidol. Fed Proc 1976;35:531.
47. Klein DF: Psychiatric diagnosis and a typology of clinical drug effects. Psychopharmacology 1968;13:359-386.
48. Akiskal HS: Subaffective disorders: Dysthymic, cyclothymic and bipolar II disorders in the ‘borderline’ realm. Psychiatr Clin North Am 1981;4:25-60.